TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
Publication
EP4087577A1
Kind: A1
Mar 18, 2026
Applicants
Principia Biopharma Inc.
Inventors
NUNN, Philip, LANGRISH, Claire, THOMAS, Dolca
IPC Classifications
A61K 31/519 20060101AFI20210716BHEP
A61P 37/06 20060101ALI20210716BHEP
A61K 45/06 20060101ALI20210716BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR